Categories

Sub categories

Total (n = 56)

n (%)

Rifampicin

P value

Sensitive (n = 18)

n (%)

Sex

Male

41 (73.2)

10 (55.6)

31 (81.6)

0.04

Female

15 (26.8)

8 (44.4)

7 (18.4)

Age

15 - 19

8 (14.3)

4 (22.2)

4 (10.5)

0.24

20 - 29

19 (33.9)

4 (22.2)

15 (39.5)

0.2

30 - 39

11 (19.6)

3 (16.7)

8 (21.1)

0.69

40 - 49

9 (16)

3 (16.7)

6 (15.8)

0.93

50 - 59

6 (10.7)

2 (11.1)

4 (10.5)

0.94

60 - 69

3 (5.5)

2 (11.1)

1 (2.6)

0.18

Location

Urban

50 (89.3)

14 (77.8)

36 (94.7)

0.055

Rural

6 (10.7)

4 (22.2)

2 (5.3)

Occupation

Service

13 (23.2)

4 (22.2)

9 (23.7)

0.9

Business

11 (19.7)

3 (16.7)

8 (21.1)

0.6

Housewife

5 (8.9)

2 (11.1)

3 (7.9)

0.6

Student

6 (10.7)

2 (11.1)

4 (10.5)

0.9

Self-employed

21 (37.5)

7 (38.9)

14 (36.8)

0.88

H/O living outside Bangladesh

Yes

4 (7.1)

2 (12.5)

2 (5.3)

0.42

No

52 (92.9)

16 (87.5)

36 (94.7)

BCG vaccine mark

Present

53 (94.6)

17 (94.4)

36 (94.7)

0.9

Absent

3 (5.4)

1 (5.6)

2 (5.3)

Risk factors

H/O TB contact

Yes

6 (10.7)

3 (16.7)

3 (7.9)

0.32

No

50 (89.3)

15 (83.3)

35 (92.1)

H/O Anti-TB treatment

New

11 (19.6)

7 (38.9)

0.012

Previously Treated

45 (80.4)

11 (61.1)

34 (89.5)

Smoking

Yes

23 (41)

3 (16.7)

20 (52.6)

0.01

No

33 (59)

15 (83.3)

18 (47.4)

Alcohol Misuse

Yes

1 (1.8)

0

1 (2.6)

-

No

55 (98.2)

18

37 (97.4)

Drug Misuse

Yes

1 (1.8)

0

1 (2.6)

-

No

55 (98.2)

18

37 (97.4)

H/O other illness

Yes

2 (3.6)

0

2 (5.3)

-

No

54 (96.4)

18

36 (94.7)